Effects of intraoperative leak testing on postoperative leak-related outcomes after primary bariatric surgery: an analysis of the MBSAQIP database

Intraoperative leak test (IOLT) is commonly performed to evaluate the integrity of an anastomosis or staple line during bariatric surgery. However, the utility of IOLT is controversial. To evaluate the effect of IOLT on postoperative leak-related outcomes after primary bariatric surgery. Metabolic a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgery for obesity and related diseases 2019-09, Vol.15 (9), p.1530-1540
Hauptverfasser: Yolsuriyanwong, Kamthorn, Ingviya, Thammasin, Kongkamol, Chanon, Marcotte, Eric, Chand, Bipan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Intraoperative leak test (IOLT) is commonly performed to evaluate the integrity of an anastomosis or staple line during bariatric surgery. However, the utility of IOLT is controversial. To evaluate the effect of IOLT on postoperative leak-related outcomes after primary bariatric surgery. Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program–accredited centers. The 2015 and 2016 Metabolic and Bariatric Surgery Accreditation and Quality Improvement databases were analyzed for sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and biliopancreatic diversion with duodenal switch (BPDDS) to determine the postoperative anastomotic/staple line leak (A/SL) and leak-related outcomes. Data for a total of 265,309 patients who underwent SG (69.6%), RYGB (29.7%), or BPDDS (.8%) were analyzed. IOLT was performed in 81.9% of all patients. Overall A/SL, mortality rate in patients with leakage, and 30-day leak-related mortality were .28%, .1%, and .003%, respectively. There were no significant differences between the IOLT and non-IOLT groups in terms of A/SL, 30-day mortality in patients with leakage, 30-day leak-related mortality, readmission, reoperation, intervention, or organ/space surgical site infection. However, the rate of 30-day leak-related intervention in BPDDS was significantly lower in the IOLT group compared to the non-IOLT group (.18% versus 1.15%, P = .01). Whether IOLT was performed endoscopically or nonendoscopically had no effect on the rate of postoperative leaks. Overall mean operative time increased by 19.1 minutes (9.5, 11.9, and 21.2 min for SG, RYGB, and BPDDS, respectively) when IOLT was performed. The overall rate of postoperative A/SL and leak-related morbidity was low. This study provided no evidence of either benefit or harm from IOLT in patients who underwent SG, RYGB, or BPDDS. •Intraoperative leak test (IOLT) was not a predictive of postoperative anastomotic/staple line leak and leak-related outcomes after primary bariatric surgery.•In BPDDS, IOLT group has the rate of 30-day leak-related intervention lower than in the non-IOLT group.•Neither endoscopic IOLT nor non-endoscopic IOLT had any effect on postoperative leaks.
ISSN:1550-7289
1878-7533
DOI:10.1016/j.soard.2019.06.008